WEST PHARMACEUTICAL SERVICES CORNWALL LIMITED
Get an alert when WEST PHARMACEUTICAL SERVICES CORNWALL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-14 (in 5mo)
Last made up 2025-09-30
Watchouts
None on the register
Cash
£24M
+26.4% vs 2023
Net assets
£40M
+21.2% vs 2023
Employees
207
-0.5% vs 2023
Profit before tax
£9M
+44.5% vs 2023
Net assets
5-year trend · vs Health Care median
Accounts
5-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | £53,566,000 | £52,839,000 | |
| Operating profit | — | — | — | £5,994,000 | £8,485,000 | |
| Profit before tax | — | — | — | £6,510,000 | £9,404,000 | |
| Net profit | — | — | — | £5,764,000 | £6,974,000 | |
| Cash | — | — | — | £19,192,000 | £24,261,000 | |
| Total assets less current liabilities | — | — | — | £33,758,000 | £40,835,000 | |
| Net assets | — | — | — | £32,837,000 | £39,811,000 | |
| Equity | £14,069,000 | £21,598,000 | £27,073,000 | £32,837,000 | £39,811,000 | |
| Average employees | — | — | — | 208 | 207 | |
| Wages | — | — | — | £8,103,000 | £8,193,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | — | — | 11.2% | 16.1% | |
| Net margin | — | — | — | 10.8% | 13.2% | |
| Return on capital employed | — | — | — | 17.8% | 20.8% | |
| Gearing (liabilities / total assets) | — | — | — | 21.6% | 24.0% | |
| Current ratio | — | — | — | 3.75x | 3.44x | |
| Interest cover | — | — | — | 139.40x | 139.10x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PKF Francis Clark
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In light of the above, the Directors consider that the going concern basis remains appropriate for the preparation of the company's accounts for the year to 31 December 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CSC CLS (UK) LIMITED | Corporate Secretary | 2026-01-26 | — | — |
| CHAN, Wai Wing Helen | Director | 2026-01-01 | Sep 1971 | British |
| GREET, David John, Mr | Director | 2024-06-15 | Sep 1975 | British |
| KEARNS, Shay | Director | 2024-06-15 | Dec 1977 | Irish |
| KILBANE, Seamus Gearoid, Mr | Director | 2024-06-15 | Apr 1964 | Irish |
| PARISH, Sean Peter | Director | 2014-03-18 | Jan 1974 | British |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHILVERS, Anthony | Secretary | — | 2002-04-15 |
| DUDART ABERDEEN, Adrian Paul | Secretary | 2002-04-15 | 2003-01-28 |
| PARISH, Sean Peter | Secretary | 2003-01-28 | 2014-03-18 |
| POPE, Darren | Secretary | 2014-03-18 | 2019-11-22 |
| THORNTON, Paul John | Secretary | 2019-11-22 | 2021-07-31 |
| CORPORATION SERVICE COMPANY (UK) LIMITED | Corporate Secretary | 2023-04-18 | 2026-01-26 |
| BATH, John Roche | Director | 1996-12-04 | 1998-04-30 |
| BAUGHMAN, Mickey Allen | Director | 1996-02-26 | 2001-05-31 |
| BRAME, Gerry | Director | 2005-05-01 | 2006-03-08 |
| BUSHEY, Rachel | Director | 2013-06-13 | 2014-07-27 |
| CHILVERS, Anthony | Director | 2001-06-01 | 2002-08-01 |
| ELLIOTT, David | Director | 2011-10-27 | 2016-12-05 |
| GAILEY III, John Robert | Director | — | 2013-06-13 |
| GOLD, Oskar Wilhelm | Director | 1996-05-24 | 1999-10-29 |
| GRIFFITHS, Alan David | Director | — | 1995-09-30 |
| GROSE, Ellen Yvette | Director | 2016-12-05 | 2024-06-30 |
| KEMPER, Martin Jozef Hubert, Dr | Director | 1995-09-30 | 1999-10-29 |
| LENNARTZ, Heino | Director | 2006-12-01 | 2018-03-31 |
| LITTLER, William | Director | 1999-11-01 | 2005-04-30 |
| MACKAY, Kimberly Banks, Mrs | Director | 2024-06-15 | 2025-12-29 |
| MILLER, George Lloyd | Director | 2016-12-05 | 2021-02-28 |
| SELKE, Stephan, Dr | Director | 2016-12-05 | 2024-04-30 |
| SMITH, Anthony | Director | 2014-03-18 | 2016-12-05 |
| TYCHSEN, Ulf Christian | Director | 1992-12-17 | 1996-03-27 |
| VAN DIJK, Ron | Director | 2005-04-30 | 2006-11-29 |
| WIMMER, Hans | Director | — | 1995-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| West Pharmaceutical Services Group Ltd | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 190 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-26 | AP01 | officers | Appoint person director company with name date | |
| 2026-03-26 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-16 | CH01 | officers | Change person director company with change date | |
| 2026-02-16 | CH01 | officers | Change person director company with change date | |
| 2026-02-16 | CH01 | officers | Change person director company with change date | |
| 2026-02-16 | CH01 | officers | Change person director company with change date | |
| 2026-01-28 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-01-28 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2026-01-28 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-10-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-30 | AA | accounts | Accounts with accounts type full | |
| 2025-09-18 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-10-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-04 | AA | accounts | Accounts with accounts type full | |
| 2024-07-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-03 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-03 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 12
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-1.4%
£53,566,000 £52,839,000
-
Cash
+26.4%
£19,192,000 £24,261,000
-
Net assets
+21.2%
£32,837,000 £39,811,000
-
Employees
-0.5%
208 207
-
Operating profit
+41.6%
£5,994,000 £8,485,000
-
Profit before tax
+44.5%
£6,510,000 £9,404,000
-
Wages
+1.1%
£8,103,000 £8,193,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers